Illumina Inc (ILMN)
116.69
-1.60
(-1.35%)
USD |
NASDAQ |
Apr 18, 16:00
116.49
-0.20
(-0.17%)
After-Hours: 06:16
Illumina Free Cash Flow: 282.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 282.00M |
September 30, 2023 | 168.00M |
June 30, 2023 | -224.00M |
March 31, 2023 | -228.00M |
December 31, 2022 | -74.00M |
September 30, 2022 | 79.00M |
June 30, 2022 | 53.00M |
March 31, 2022 | 208.00M |
December 31, 2021 | 337.00M |
September 30, 2021 | 469.00M |
June 30, 2021 | 898.00M |
March 31, 2021 | 890.00M |
December 31, 2020 | 891.00M |
September 30, 2020 | 933.00M |
June 30, 2020 | 1.046B |
March 31, 2020 | 941.00M |
December 31, 2019 | 842.00M |
September 30, 2019 | 691.00M |
June 30, 2019 | 701.00M |
March 31, 2019 | 823.00M |
December 31, 2018 | 846.00M |
September 30, 2018 | 829.00M |
June 30, 2018 | 752.00M |
March 31, 2018 | 643.00M |
December 31, 2017 | 563.00M |
Date | Value |
---|---|
September 30, 2017 | 525.00M |
June 30, 2017 | 482.00M |
March 31, 2017 | 547.00M |
December 31, 2016 | 508.00M |
September 30, 2016 | 659.42M |
June 30, 2016 | 702.95M |
March 31, 2016 | 658.77M |
December 31, 2015 | 643.00M |
September 30, 2015 | 387.80M |
June 30, 2015 | 346.95M |
March 31, 2015 | 371.83M |
December 31, 2014 | 359.06M |
September 30, 2014 | 373.87M |
June 30, 2014 | 327.39M |
March 31, 2014 | 247.41M |
December 31, 2013 | 295.86M |
September 30, 2013 | 265.71M |
June 30, 2013 | 223.75M |
March 31, 2013 | 224.41M |
December 31, 2012 | 210.86M |
September 30, 2012 | 230.52M |
June 30, 2012 | 276.14M |
March 31, 2012 | 254.78M |
December 31, 2011 | 278.59M |
September 30, 2011 | 267.00M |
Free Cash Flow Range, Past 5 Years
-228.00M
Minimum
Mar 2023
1.046B
Maximum
Jun 2020
468.58M
Average
469.00M
Median
Sep 2021
Free Cash Flow Benchmarks
Exact Sciences Corp | 31.93M |
Guardant Health Inc | -345.46M |
Quest Diagnostics Inc | 864.00M |
Natera Inc | -286.15M |
Castle Biosciences Inc | -19.25M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 224.00M |
Cash from Investing (Quarterly) | -85.00M |
Cash from Financing (Quarterly) | -27.00M |
Free Cash Flow Per Share (Quarterly) | 1.095 |
Free Cash Flow to Equity (Quarterly) | 173.00M |
Free Cash Flow to Firm (Quarterly) | 180.34M |
Free Cash Flow Yield | 1.53% |